Retatrutide is a new pharmaceutical in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these receptors, Retatrutide reduces hunger pangs, {promotesinsulin secretion, and ultimately leads to significant weight loss. While studies a